Form 4 holding
Director
Addex Therapeutics Ltd.
- Security class
- Common Stock
- Shares / value
- 219,561
- Estimated value
- Report date
- 02 Sep 2026
- Price
- Ownership
- Direct
Jason Raleigh Nunn - Director at Addex Therapeutics Ltd.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- ADXN on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Jason Raleigh Nunn since 18 Sep 2025
Reported holdings for Jason Raleigh Nunn in Addex Therapeutics Ltd.
Form 4 holding
Director
Addex Therapeutics Ltd.
- Security class
- Stock-option (Right to Buy)
- Shares / value
- 50,000
- Estimated value
- Report date
- 02 Sep 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Jason Raleigh Nunn in Addex Therapeutics Ltd.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.